ロード中...
Stem cell pathways contribute to clinical chemoresistance in ovarian cancer
PURPOSE: Within heterogeneous tumors, subpopulations often labeled cancer stem cells (CSCs) have been identified that have enhanced tumorigenicity and chemoresistance in ex vivo models. However, whether these populations are more capable of surviving chemotherapy in de novo tumors is unknown. EXPERI...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3271164/ https://ncbi.nlm.nih.gov/pubmed/22142828 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-2188 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|